Shaoyi Zhang

Prof. Shaoyi Zhang

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2022 in Nature
Verified
Journal Article
Closed access
PDF file
MAMargaret L. Axelrod
Margaret L. Axelrod
WMWouter C. Meijers
Wouter C. Meijers
ESElles M. Screever
Elles M. Screever
JQJuan Qin
Juan Qin
MCMary Grace Carroll
Mary Grace Carroll
JBJustin M. Balko
Justin M. Balko

4 September 2022 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
WPWenyuan Pu
Wenyuan Pu
ZSZhenzi Su
Zhenzi Su
JWJunaid Wazir
Junaid Wazir
CZChen Zhao
Chen Zhao
LWLulu Wei
Lulu Wei
hongwei wanghongwei wang
hongwei wang
Background: Inflammatory bowel disease (IBD) is a common chronic remitting disease with no satisfactory treatment. The aim of this study was to investigate the protective effect of α7 nicotinic acetylcholine receptor (α7nAChR), and to determine the underlying mechanism of its activity. Methods: The expression and distribution of α7nAChR in the intestinal tissue of patients with ulcerative colitis and Crohn’s disease were analyzed. The effects of vagal excitation on murine experimental colitis were investigated. The colitis model was induced in C57BL/6 mice by the administration of 3% dextran sulfate sodium (DSS). The therapeutic group received treatment with the α7nAChR agonist PNU-282987 by intraperitoneal injection. Results: Our results showed that there was significantly increased expression of α7nAChR in colitis and Crohn’s disease intestinal tissue, and its expression was mainly located in macrophages and neutrophils, which were extensively infiltrated in the disease status. Treatment with an α7nAChR agonist potently ameliorated the DSS-induced illness state, including weight loss, stool consistency, bleeding, colon shortening, and colon histological injury. α7nAChR agonist exerted anti-inflammatory effects in DSS colitis mice by suppressing the secretion of multiple types of proinflammatory factors, such as IL6, TNFα, and IL1β, and it also inhibited the colonic infiltration of inflammatory cells by blocking the DSS-induced overactivation of the NF-κB and MAPK signaling pathways. Mechanistically, activation of α7nAChR decreased the number of infiltrated M1 macrophages in the colitis intestine and inhibited the phagocytosis ability of macrophages, which were activated in response to LPS stimulation. Conclusion: Thus, an α7nAChR agonist ameliorated colonic pathology and inflammation in DSS-induced colitis mice by blocking the activation of inflammatory M1 macrophages.

15 April 2014 in World Journal of Emergency Surgery
Verified
Journal Article
Open access
PDF file
JYJianyi Yin
Jianyi Yin
ZZZhenguo Zhao
Zhenguo Zhao
YLYousheng Li
Yousheng Li
JWJian Wang
Jian Wang
DYDanhua Yao
Danhua Yao
JLJieshou Li
Jieshou Li
The optimal transfusion protocol remains unknown in the trauma setting. This retrospective cohort study aimed to determine if goal-directed transfusion protocol based on standard thrombelastography (TEG) is feasible and beneficial in patients with abdominal trauma.

22 August 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
FGFengbiao Guo
Fengbiao Guo
Shaoyi ZhangShaoyi Zhang
Shaoyi Zhang
Intestinal regeneration is essential for maintaining epithelial integrity and repairing mucosal damage caused by inflammation, infections, or injuries. Traditional Chinese Medicine (TCM) has long utilized herbal remedies for gastrointestinal disorders, and accumulating evidence highlights that natural compounds derived from TCM possess significant regenerative potential. This review summarizes the multifaceted mechanisms by which these bioactive compounds promote intestinal healing. Key actions include the stimulation of intestinal stem cell (ISC) proliferation and differentiation, the modulation of inflammatory responses, the reinforcement of epithelial barrier integrity, the attenuation of oxidative stress, and the reshaping of the gut microbiota. Representative compounds such as Astragalus polysaccharides, berberine, curcumin, puerarin, and flavonoids like quercetin exhibit these effects through signaling pathways, including HIF-1, Wnt/β-catenin, NF-κB, Nrf2, and IL-22. Evidence from in vitro organoid models and in vivo studies in colitis, radiation injury, antibiotic-associated diarrhea, and intestinal dysmotility and diarrhea models demonstrates that these compounds enhance crypt villus regeneration, preserve tight junctions, and improve clinical outcomes. The holistic, multi-target actions of Chinese medicine-derived natural products make them promising candidates for therapeutic strategies aimed at intestinal repair. Further clinical validation and mechanistic studies are warranted to facilitate their integration into modern gastrointestinal medicine.

26 November 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
PLPing Liao
Ping Liao
ZCZhonghao Chen
Zhonghao Chen
YGYang Gao
Yang Gao
YYYang Yang
Yang Yang
YCYibo Chen
Yibo Chen
XCXin Chen
Xin Chen
CD4 + Foxp3 + regulatory T cells (Tregs) are essential for maintaining immune tolerance, and selective expansion of Tregs via TNFR2 signaling represents a promising therapeutic approach for autoimmune and inflammatory diseases. Here, we report the identification and characterization of UMR2-705, a novel TNFR2 agonist discovered through phage display screening. In vitro , peptide UMR2–705 selectively promoted Treg proliferation in both human peripheral blood mononuclear cells and murine CD4 + T cell cultures without stimulating conventional CD4 + effector or CD8 + T cells. This effect was abrogated by the TNFR2-specific blocking antibody TR75-54.7, indicating its TNFR2 dependency. In vivo , administration of peptide UMR2–705 expanded Tregs in murine spleen and lymph nodes, attenuated LPS-induced systemic cytokine release (IL-6, TNF-α, IL-17A) in serum, and preserved immune homeostasis during systemic inflammation through TNFR2-dependent modulation of the regulatory compartment. Transcriptomic profiling revealed activation of TNFR2-associated signaling and upregulation of immune-regulatory pathways. These findings identify peptide UMR2–705 as a selective, peptide-based TNFR2 agonist with potent Treg-expanding and anti-inflammatory activities, supporting its potential as a therapeutic candidate for autoimmune and inflammatory disorders.

3 April 2019 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
Shaoyi ZhangShaoyi Zhang
Shaoyi Zhang
Yan WANGYan WANG
Yan WANG
WXWei Xie
Wei Xie
EHEthan Howe
Ethan Howe
NBNathalie Busschaert
Nathalie Busschaert
Guido KroemerGuido Kroemer
Guido Kroemer
In the version of this article originally submitted, it was stated that the first three authors (Shaoyi_ Than, Yan Wang, Wei Xie) had contributed equally. However, in the published version this information was missing.